Research programme: oncolytic virus cancer therapeutics - Microbial Robotics

Drug Profile

Research programme: oncolytic virus cancer therapeutics - Microbial Robotics

Alternative Names: oHSV rQT3 ViruBot

Latest Information Update: 14 Oct 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bacterial Robotics
  • Developer Microbial Robotics
  • Class Oncolytic viruses
  • Mechanism of Action Tissue inhibitor of metalloproteinase-3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 10 Oct 2014 Bacterial Robotics is now called Microbial Robotics
  • 23 Jun 2014 Preclinical trials in Cancer in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top